Meningococcal serogroup C polysaccharide capsule — Drug Target

All drugs that target Meningococcal serogroup C polysaccharide capsule — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Meningococcal conjugate vaccine · Conjugate vaccine

Marketed (1)

• Menjugate® · GlaxoSmithKline · Meningococcal conjugate vaccine · Immunology / Infectious Disease
  Menjugate is a meningococcal conjugate vaccine that stimulates the immune system to produce antibodies against serogroup C meningococcal polysaccharide capsule.

Phase 3 pipeline (1)

• MeningitecTM · GlaxoSmithKline · Conjugate vaccine · Immunology / Infectious Disease
  Meningitec is a conjugate vaccine that stimulates the immune system to produce antibodies against meningococcal serogroup C polysaccharide capsule.